homefeedbacksupportlog on 1-Dec-2008 
  Search
 
   
 
  Top 10s
 Cardiovascular Disorders
  Current Top 10 by F1000 Factor
  All Time Top 10 by F1000 Factor
  Most viewed Top 10
(from all journals)
  Most viewed Top 10
(from specialty journals)
  Hidden Jewels

  Sections Covered
Arrhythmias, Electrophysiology & Pacing
Cardiovascular Imaging
Congenital Heart Disease
Coronary Artery Disease
Geriatric Cardiology
Heart Failure
Hypertension
Valvular Disease
Vascular Diseases (Non-Coronary)
Related Sections
Acute Cardiovascular Problems
Hemodynamics, Vasc. Biology & Hypertension Sec. to Kidney Dis.
Pulmonary Vascular Diseases


 MOST VIEWED TOP 10 (from all journals) | Cardiovascular Disorders | calculated on 1 December 2008

The "Most Viewed Top 10 (from all journals)" Top 10 lists are generated every day. The articles are ordered by the number of times an article's evaluation(s) has/have been viewed over the past 30 days.

 browse faculty | show Most Viewed (all journals) Papers in

to email [Help]


1
Must Read
F1000 Factor 4.8

Confirmation
 Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention.
Lin GA, Dudley RA, …, Vittinghoff E, Redberg RF
JAMA 2008 Oct 15 300(15):1765-73 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | John Augoustides with Harish Ramakrishna / Richard Underwood with Jim Stirrup
First evaluation 5 Nov 2008 | Latest evaluation 24 Nov 2008
 
2
Exceptional
F1000 Factor 7.6

Confirmation
Hypothesis
New Finding
Controversial
Refutation
 Hydrocortisone therapy for patients with septic shock.
Sprung CL, Annane D, …, Briegel J, CORTICUS Study Group
N Engl J Med 2008 Jan 10 358(2):111-24 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Patrick Ray / Judy Kersten with Julien Amour / Greg McAnulty / Martin Dunser / John Laffey / Eric Nylen / Martin Llewelyn / Alain Vuylsteke / Robert Dluhy with Florencia Halperin
Dissenters | Greg Martin / Didier Journois with Guillaume Dubreuil
Author Response | Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J, CORTICUS Study Group
First evaluation 21 Jan 2008 | Latest evaluation 28 Oct 2008

 
3
Exceptional
F1000 Factor 9.0

New Finding
Controversial
 Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein.
Ridker PM, Danielson E, …, Glynn RJ, the JUPITER Study Group
N Engl J Med 2008 Nov 20 359(21):2195-2207 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Melvin Cheitlin
Evaluated 28 Nov 2008
 
4
Recommended
F1000 Factor 3.0

Confirmation
 A critical review of the American College of Cardiology/American Heart Association practice guidelines on bicuspid aortic valve with dilated ascending aorta.
Guntheroth WG
Am J Cardiol 2008 Jul 1 102(1):107-10 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Candice Silversides with Matthias Greutmann
Evaluated 11 Nov 2008
 
5
Exceptional
F1000 Factor 10.7
Articles that inform your practice or change your way of thinking Changes
Clinical Practice

Confirmation
New Finding
 Treatment of hypertension in patients 80 years of age or older.
Beckett NS, Peters R, …, Bulpitt CJ, HYVET Study Group
N Engl J Med 2008 May 1 358(18):1887-98 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Deepak Bhatt with Dharam Kumbhani / Ramachandran S. Vasan / Jerome Fleg / Annemarie Hennessy / Ernesto Schiffrin / Wilbert Aronow / Kazuomi Kario with Joji Ishikawa
First evaluation 14 Apr 2008 | Latest evaluation 3 Jun 2008
 
6
Recommended
F1000 Factor 3.0

Confirmation
 Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study.
Douketis J, Cook D, …, Crowther M, Canadian Critical Care Trials Group
Arch Intern Med 2008 Sep 8 168(16):1805-12 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Mark Hamilton with Marcus Peck
Evaluated 28 Oct 2008
 
7
Recommended
F1000 Factor 3.0

Confirmation
 Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.
Khan MN, Jaïs P, …, Natale A, PABA-CHF Investigators
N Engl J Med 2008 Oct 23 359(17):1778-85 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Marrick Kukin with Catherine Weinberg
Evaluated 7 Nov 2008
 
8
Must Read
F1000 Factor 6.0

Controversial
 Beta-blocker use and outcomes among hospitalized heart failure patients.
Butler J, Young JB, …, O'Connor C, ESCAPE Investigators
J Am Coll Cardiol 2006 Jun 20 47(12):2462-9 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Maryl Johnson
Evaluated 14 Jul 2006
 
9
Exceptional
F1000 Factor 9.8
Articles that inform your practice or change your way of thinking Changes
Clinical Practice

Confirmation
Hypothesis
New Finding
Controversial
 Rhythm control versus rate control for atrial fibrillation and heart failure.
Roy D, Talajic M, …, Waldo AL, Atrial Fibrillation and Congestive Heart Failure Investigators
N Engl J Med 2008 Jun 19 358(25):2667-77 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Brian Olshansky with Chirag Sandesara / Wilbert Aronow / Hector Ventura with Anil Verma
First evaluation 15 Jul 2008 | Latest evaluation 11 Aug 2008
 
10
Must Read
F1000 Factor 6.0

Confirmation
 Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy.
Ypenburg C, van Bommel RJ, …, Schalij MJ, Bax JJ
J Am Coll Cardiol 2008 Oct 21 52(17):1402-9 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | I Eli Ovsyshcher
Evaluated 20 Nov 2008

© 2008 Medicine Reports Ltd unless otherwise stated. < info@f1000.com >   Terms and conditions   Legal info